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Recent success in the treatment of congenital blindness demonstrates the potential of ocular gene therapy as a therapeutic approach.
The eye is a good target due to its small size, minimal diffusion of therapeutic agent to the systemic circulation, and low immune
and inflammatory responses. Currently, most approaches are based on viral vectors, but efforts continue towards the synthesis and
evaluation of new nonviral carriers to improve nucleic acid delivery. Our objective is to evaluate the efficiency of novel cationic
retinoic and carotenoic glycol phospholipids, designated C20-18, C20-20, and C30-20, to deliver DNA to human retinal pigmented
epithelium (RPE) cells. Liposomes were produced by solvent evaporation of ethanolic mixtures of the polyene compounds
and coformulated with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) or cholesterol (Chol). Addition of DNA to the
liposomes formed lipoplexes, which were characterized for binding, size, biocompatibility, and transgene efficiency. Lipoplex
formulations of suitable size and biocompatibility were assayed for DNA delivery, both qualitatively and quantitatively, using RPE
cells and a GFP-encoding plasmid. The retinoic lipoplex formulation with DOPE revealed a transfection efficiency comparable to
the known lipid references 3𝛽-[N-(N󸀠,N󸀠-dimethylaminoethane)-carbamoyl]-cholesterol (DC-Chol) and 1,2-dioleoyl-sn-glycero-
3-ethylphosphocholine (EPC) and GeneJuice. The results demonstrate that cationic polyene phospholipids have potential as DNA
carriers for ocular gene therapy.
1. Introduction
Gene therapy is a promising treatment of several pathologies
[1] and has been successfully employed to cure eye diseases.
The eye possesses several advantages for gene therapy: (1)
it is a small organ, requiring only minor amounts of gene
carriers; (2) it is a spatially confined and compartmentalized
organ; (3) its tissues are readily accessible by microsurgical
techniques; (4) it has transparent structures visualized by
direct noninvasive techniques; (5) it is separated from sys-
temic circulation by the blood-retinal barrier and therefore is
an immune privileged organ; (6) it offers a proximate control
(the untreated eye) [2–4]; (7) several eye pathologies are
monogenic; and (8) mutations are identified.
Successful gene therapy requires nucleic acid carriers of
minimal toxicity allowing long and stable gene expression,
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such as adenovirus and lentivirus [5]. Nevertheless, the use
of viral gene carriers is limited by costly and time-consuming
production, restricted cloning capacity, and most important
severe immune responses [3, 6]. Nonviral carriers have the
potential to overcome these drawbacks, although the effi-
ciency of nonviral carriers still falls behind viral systems [2, 4,
7, 8].Therefore, there is a need to develop novel synthetic car-
riers which package and protect the nucleic acid cargo, suc-
cessfully travel across the cytoplasmic membrane, and ulti-
mately release their nucleic acid load for nuclear uptake [5].
Nonviral carriers are typically cationic polymers or lipo-
somes. Cationic liposomes can easily be produced in large
scale [9], can be made tissue specific, have the ability to inter-
act with biological membranes, are well internalized by cells,
display low toxicity, and are able to escape the endosome [7].
Cationic lipids interact with negatively charged nucleic
acids through a combination of electrostatic and hydrophobic
interactions, resulting in lipoplexes of multilamellar struc-
tures [7]. The structure and shape of the lipoplex and its
lipid/nucleic acid molar ratio are decisive for successful gene
delivery [10].
The transfection efficiency and biocompatibility of
cationic lipid gene carriers can be altered by modifications
of the constituent parts of the lipids, specifically, the lipid
backbone (often glycerol), the hydrophilic head group, and
the interconnecting linker. Less diversity is reported for the
hydrophobic part, which is known to play a significant role
in the morphology of the lipoplex [4]. The cationic head
group is largely responsible for toxicity and determines the
strength of the electrostatic attraction for the negatively
charged nucleic acid. Linker groups such as amides, esters,
and ethers define the site for lipid cleavage, which is again
associated with cytotoxicity [11]. The hydrophobic domain
usually consists of one or two saturated or monounsaturated
hydrocarbon chains.
Dietary carotenoids are known to enhance visual perfor-
mance and to reduce the risk of AMD progression [12]. The
glycol lipids, investigated in this report, consist of retinoic
(C20:5) and carotenoic (C30:9) polyene chains, combined
with a C20:0 and C18:0 chains (Figure 1) [13].
Our objective was to evaluate the gene delivery effi-
ciency and cytotoxicity of the cationic polyene glycol lipids
against the reference glycerol lipids 3𝛽-[N-(N󸀠,N󸀠-dimeth-
ylaminoethane)-carbamoyl]-cholesterol (DC-Chol) and 1,2-
dioleoyl-sn-glycero-3-ethylphosphocholine (EPC; referred to
elsewhere as “diC14-EPC” [14]) (Figure 2) in human retinal
pigmented epithelium (RPE) cells.
The polyene lipids were formulated with either choles-
terol (Chol) or 1,2-dioleoyl-sn-glycero-3-phosphoethanol-
amine (DOPE) (Figure 3), and the impact of these colipids
on gene delivery and cellular toxicity was assessed.
2. Materials and Methods
2.1. GeneralMaterials. TheARPE-19 cell line, a human retinal
pigment epithelial cell line, was kindly provided by Dr. Fran-
scisco Ambro´sio (Center for Neuroscience and Cell Biology,
University of Coimbra, Portugal); Dulbecco’s modified eagle
medium (DMEM) culture medium and Dulbecco’s modified
eagle medium F12 ham (DMEM F12 Ham) culture medium,
fetal bovine serum (FBS), trypsin, glutamine, penicillin-
streptomycin solution, dichloromethane, thiazolyl blue tetra-
zolium bromide (MTT), 0.04 N HCl in 2-propanol con-
stituents, dd-water, tris-acetate-EDTA (TAE) constituents,
Avertin anesthesia constituents (tribromoethanol), Triton X-
100, Mowiol mounting media constituents, sucrose (saccha-
rose), paraformaldehyde, eosin, acetic acid, dibutyl phthalate
xylene (DPX), sodium phosphate, potassium phosphate, and
goat serum stock were purchased from Sigma-Aldrich (Por-
tugal). Absolute ethanol was purchased fromMerckMillipore
(Portugal).
PlasmidDNA containing the reporter gene green fluores-
cent protein (GFP) was kindly provided by Dr. Jean Bennett
(University of Pennsylvania, USA). Agarose was purchased
from Invitrogen (Portugal). GreenSafe and GeneJuice were
purchased from NZYTech (Portugal). For the phosphate
buffered saline (PBS), sodium chloride, potassium chloride,
4󸀠,6-diamidino-2-phenylindole (DAPI), and optimal cutting
temperature (OCT) cryostat embedding solution were pur-
chased from VWR (Portugal). Primary antibody Iba1, a
microglia marker, was purchased fromWako Pure Chemical
Industries (Japan) and secondary antibody Alexa 594 was
purchased from Invitrogen (Portugal). Oxalic acid, potas-
sium permanganate (KMnO
4
), and hematoxylin were pur-
chased fromMerck (Portugal). Control cationic lipids 3𝛽-[N-
(N󸀠,N󸀠-dimethylaminoethane)-carbamoyl]-cholesterol (DC-
Chol) and 1,2-dimyristoyl-sn-glycero-3-ethylphosphocholine
(EPC) [14] and the neutral colipids cholesterol (Chol) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were
obtained from Avanti Polar Lipids (Alabaster, AL, USA).
2.2. Cationic Polyene Lipids: C20-18, C20-20, and C30-20.
Three cationic polyene lipids, C20-18, C20-20, and C30-20,
were synthesized from glycol, retinoic acid (C20:5) or C30-
acid (C30:9), and choline precursors as reported elsewhere
[13, 15].
2.3. Preparation of Lipid Ethanolic Stock Solutions. Ethanolic
stock solutions were made separately by first dissolving
each cationic lipid and colipid in dichloromethane. The
dichloromethane was removed under reduced pressure with
a rotary evaporator, and then the residue dissolved in absolute
ethanol to a final lipid concentration of 1mM and subse-
quently stored at −80∘C.
2.4. Preparation of Liposome Formulations. Cholesterol and
DOPE were employed as neutral colipids [4]. Liposomes
of C20-18/Chol, C20-20/Chol, C30-20/Chol, C20-18/DOPE,
C20-20/DOPE, and C30-20/DOPE in a lipid/colipid molar
ratio of 3 : 2 were generated by mixing ethanolic solutions of
cationic lipid and colipid and removing the ethanol under
reduced pressure.The resulting thin filmswere then dissolved
in dd-water to a final lipid concentration of 2mM, and
incubated overnight at 4∘C. Prior to use, these hydrated
liposome stocks were warmed to room temperature and then
subjected to ultrasounds for 30 minutes at 60∘C. The known
cationic lipids DC-Chol and EPC were used as controls.
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Figure 1: C20-18, C20-20, and C30-20 cationic amphiphilic glycol polyene phospholipids. The color of the polyene chain indicates
approximately the visually appearance of the compounds. Glycol backbone green, hydrophilic part blue.
2.5. Preparation of Lipoplex Formulations. The addition of
predetermined volumes of negatively charged plasmid DNA
to positively charged liposomes resulted in lipoplex for-
mulations of defined nitrogen-to-phosphorus (N/P) molar
charge ratios. DNA contained the reporter gene GFP. Lipid
concentrations, derived from a 2mM hydrated stock, were
0.243mM, 0.162mM, and 0.081mM, which correlates with
the molar charge ratios of 1.5 : 1, 1 : 1, and 0.5 : 1, respectively.
Equal volumes of DNA solution in DMEM or DMEM/F12
Ham culture medium and lipids were mixed and incubated
at room temperature for 30min to allow lipoplex formation.
2.6. Evaluation of Lipid-DNABinding. Agel retardation assay
was used to evaluate lipoplex formation, as a neutral or
net positive charge associated with the lipid-DNA complex
retards migration through agarose gel. Lipoplexes with vary-
ing lipid : DNA ratios were prepared as described above in a
total volume of 20𝜇L. Samples were loaded onto a 1% agarose
gel impregnated with GreenSafe and electrophoresed at 70V
in tris-acetate-EDTA (TAE) buffer. The DNA bands were
observed using an ultraviolet transilluminator.
2.7. Physicochemical Characterization of the Lipoplexes. Lip-
oplexes were prepared in phosphate buffered solution (PBS),
for subsequent determination of size and zeta potential by
dynamic light scattering (DLS) and laser Doppler anemom-
etry, respectively, using a Zetasizer Nanoseries ZS (Malvern
Instruments) by diluting the sample 50x with dd-water.
The size and size distribution of lipoplexes are indicated
as displayed by the instrument. Measurement parameters
were as follows: a laser wavelength of 633 nm and a
scattering angle of 173∘ (fixed). The samples were loaded
into polystyrene cuvettes and three measurements were
performed, for which the mean result was recorded. Particles
with PdI > 0.7 and 𝑑H > 2000 nm may be outside of the
instrument’s reliable range.
2.8. Evaluation of the In Vitro Cytotoxicity of Lipoplexes.
D407 cells were maintained in DMEM culture medium
supplemented with 5% FBS, 1% glutamine, and 1% penicillin-
streptomycin solution at 37∘C with 5% CO
2
. ARPE-19 cells
were maintained in DMEM F12 HAM culture medium
supplemented with 10% FBS, 1% glutamine, and 1%
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Figure 2: Reference compounds. DC-Chol and cationic glycerophosphospholipid EPC with two C14:0 chains. Glycerol backbone green,
hydrophilic parts blue.
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Figure 3: Colipids. Neutral cholesterol (Chol) and zwitterionic glycerophosphospholipid DOPE with two C18:1 chains. Glycerol backbone
green, hydrophilic parts blue.
penicillin/streptomycin at 37∘C with 5% CO
2
. For the
cytotoxicity assays, cells were seeded at 35,000 cells per well
(D407) or 65,000 cells per well (ARPE-19) in 24-well plates
in complete medium and incubated for 24 h at 37∘C and
5% CO
2
. Cell seeding numbers differ with cell line due to
differences in cell doubling rate. After 24 h, cells were washed
with PBS and 250 𝜇L lipoplex formulations with various
N/P molar charge ratios added to each well. After a 4-hour
incubation period, 366𝜇L of culture medium was added.
Cells were incubated for 24, 48, and 72 h. Cell viability was
determined by the standard MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay. Briefly, after the
incubation period, 50𝜇L of a 5mg/mL MTT in PBS solution
was added per well, followed by a 4 h incubation period,
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after which the culture medium was removed and 500𝜇L
of a 0.04N HCl in 2-propanol solution was added per well.
After dissolution of the formazan crystals, their absorbance
was measured at 570 and 630 nm for each well. Cell viability
was obtained by measurement of optical densities and
normalization against the positive control, consisting of cells
grown in standard culture medium.
2.9. Evaluation of the In Vitro Transfection Efficiency of
Lipoplexes. Transfection was determined using cells seeded
at 100,000 cells per well (D407) or 250,000 cells per well
(ARPE-19) in 6-well plates in complete growth medium
and incubated at 37∘C with 5% CO
2
for 24 h. Cell seeding
numbers differ with cell line due to differences in cell dou-
bling rate. Immediately prior to transfection, cell monolayers
were washed with PBS. The lipoplex formulations at various
N/P molar charge ratios were added to each well in culture
medium up to 2mL and incubated for 4 h at 37∘C, 5% CO
2
.
After this period, the medium containing the lipoplexes was
removed, the cells were washed with PBS, and complete
growth medium was added and further incubated for 72 h at
37∘C, 5% CO
2
. Subsequently, the cells were suspended using
trypsin, washed with PBS, and resuspended in 500𝜇L of PBS
for flow cytometry analysis (BD FACSCalibur Flow Cytome-
ter, BD Biosciences). Transfection efficiency was assessed by
detection of GFP with results normalized for 10,000 events.
2.10. Evaluation of the In Vivo Cytotoxicity of Lipoplexes. The
in vivo compatibility of the C20-20/DOPE/DNA (N/P molar
charge ratio 0.5 : 1) was evaluated by intravitreal injection of
the lipoplexes dispersed in PBS into C57Bl6 mice. C57BL6
mice (6 months old) were housed at controlled temperature
with 12 h light/dark cycle and food and water ad libitum.
All experimental procedures involving animals were carried
out in accordance with the Portuguese and European Union
regulations (FELASA) and the Association for Research
in Vision and Ophthalmology (ARVO). All experimental
injections were performed under anesthesia administered
by intraperitoneal injection (250mg/kg dose). Intravitreal
injection was performed under a stereomicroscope (Nikon
Stereoscopic Microscope) with a 30-gauge needle. Only one
eye was injected; the contralateral eye was left noninjected as
control. Fourteen days postinjection, themice were sacrificed
by cervical dislocation and the eyes were enucleated and
preserved in PFA 4% at 4∘C until further use. The eyes
were treated with 30% sucrose solution and embedded in
OCT (Optimal Cutting Temperature) embedding solution
and stored at −80∘C. Cryosections of 10 𝜇m thickness were
used for detection of Iba1 (ionized calcium-binding adapter
molecule 1, a marker of active microglia used to detect local
inflammation) by immunohistochemistry. Cryosectionswere
permeabilized with PBS/0.1% Triton X-100 and washed twice
with PBS. A 1 : 1000 dilution of the Iba1 antibody was used,
and the samples incubated overnight at 4∘C in the dark.
Samples were washed three times with PBS/0.1% Triton X-
100 and a 1 : 2000 dilution of the secondary antibody Alexa
594 was used for detection and incubated for 1 h, at room
temperature, in the dark. Samples were washed three times
with PBS/0.1% Triton x-100, mounted, and visualized by
fluorescencemicroscopy (Zeiss Axio Imager Z2 Fluorescence
Microscope). Samples were counterstained with DAPI (4󸀠,6-
diamidino-2-phenylindole), a marker for nuclear detection.
Cryosections were also used for hematoxylin and eosin
staining to analyze the retina for its morphology and major
signs of inflammation. Sections were washed with distilled
water, stained with hematoxylin for 1min, washed with
distilled water, stained with 1% eosin for 5min, washed with
0.2% acetic acid, and mounted with DPX (dibutyl phthalate
xylene). Samples were visualized under bright field (Zeiss
Axio Imager Z2 Fluorescence Microscope).
2.11. Statistical Analysis. All figures are representative of at
least 3 separate experiments. For comparison of multiple sets
of data one-way ANOVA, including the Dunnet post-test,
was performed. Results are expressed as mean +/− SEM.
Statistical analysis was performed using GraphPad Prism 6
Software with 𝑃 < 0.05 considered statistically significant.
3. Results
3.1. Polyene Lipids Form Stable Lipid-DNA Complexes
(Lipoplexes). The size and surface charge of lipid-DNA
complexes composed of the polyene lipids were determined
using Dynamic Light Scattering (DLS) (Table 1). The
lipoplexes were prepared in PBS, since this was the vehicle
used for further experiments. The average size range of
lipoplexes composed of reference lipids DC-Chol and EPC
was 𝑑H (hydrodynamic diameter) = 320–2010 nm, while
for those composed of C20-18, C20-20, and C30-20 was
𝑑H = 320–2210 nm. The average size of the lipoplexes did
not correlate with increasing N/P ratio, with the exception
of EPC/DOPE and C20-18/Chol (denoted by ∗), and also
did not correlate with formulation of the same lipid with
different colipids, Chol, and DOPE, with the exception
of EPC and C30-20 lipoplexes (denoted by †). DLS is a
technique that depends on the scattering of light with the
particles and polydispersity may “hide” real populations due
to the presence of large particles. Table 1 shows the mode,
which is the most frequent size in the samples. If samples
are monodisperse, 𝑑H values are representative of the sample
and will be similar to the mode. However if the sample is
polydisperse, 𝑑H values represent less accurately the sample
and its value is apart from the mode [16].
The surface charge values (as measured by zeta potential,
ZP, Table 1) indicate stable particles. The lipoplexes of the
reference lipids revealedZP = −54±2–−69±3mV,whereas the
polyene lipoplexes revealed a broader range with ZP = −30 ±
2– −66 ± 1mV.The ZP ranges did not correlate with particle
size, as the reference lipids were found to have a narrow ZP
range yet generally broader particle distribution compared
with the polyene lipoplexes. Significant size changes were not
associated with significant changes in ZP. Furthermore, ZP
values are not correlated with increasing N/P ratio, except for
C30-20/Chol.
The cationic liposomes were combined with a GFP-coded
plasmid DNA to evaluate relative gene transfer efficiency to
RPE cells. The DNA binding efficiency of C20-18, C20-20,
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Table 1: Size and surface charge (as measured by zeta potential, ZP) of C20-18, C20-20, C30-20, DC-Chol, and EPC lipoplexes in PBS at
varying N/P molar charge ratios with either Chol or DOPE as colipids.
Lipid Colipid 𝑁/𝑃 ratio dH (nm) Mode (nm) Pdl ZP (mV)
DC-Chol
0.5 : 1 1180 477 0.718 −55 ± 5.61
Chol 1 : 1 1480 455 0.840† −55 ± 5.19
1.5 : 1 1220 516 0.611 −65 ± 3.11
0.5 : 1 900 441 0.664 −63 ± 0.65
DOPE 1 : 1 1310 600 0.424 −69 ± 2.76
1.5 : 1 1290 506 0.768∗ −65 ± 1.06
EPC
0.5 : 1 510† 488 0.220† −54 ± 1.65
Chol 1 : 1 360 380 0.058 −57 ± 1.01
1.5 : 1 320† 322† 0.234† −57 ± 0.85
0.5 : 1 1410 528 0.750 −57 ± 1.22
DOPE 1 : 1 930 625 0.366 −58 ± 1.96
1.5 : 1 2010∗ 656 0.862 −54 ± 1.98
C20-18
0.5 : 1 320 256 0.322 −41 ± 10.81
Chol 1 : 1 390 361 0.285 −51 ± 4.57
1.5 : 1 1523∗ 490 0.702∗ −43 ± 8.11
0.5 : 1 550 487 0.425 −53 ± 6.73
DOPE 1 : 1 910 406 0.624 −38 ± 7.77
1.5 : 1 1270 453 0.596 −36 ± 1.74
C20-20
0.5 : 1 560 548 0.130 −53 ± 0.27
Chol 1 : 1 570 537 0.157 −59 ± 1.03
1.5 : 1 660 537 0.257 −61 ± 0.37
0.5 : 1 640 465 0.304 −53 ± 1.43
DOPE 1 : 1 970 500 0.155 −41 ± 0.88
1.5 : 1 750 594 0.147 −62 ± 0.50
C30-20
0.5 : 1 500† 355∗† 0.353 −36 ± 1.43∗
Chol 1 : 1 820 763 0.178 −60 ± 1.86†
1.5 : 1 710 697 0.260 −66 ± 0.58†
0.5 : 1 1500 937∗ 0.144 −30 ± 1.71
DOPE 1 : 1 970 605 0.419 −40 ± 1.43
1.5 : 1 1140 768 0.220 −40 ± 0.12
†Comparison between Chol and DOPE formulations of one lipid with the samemolar charge ratio; ∗Comparison between ratios (0.5 : 1 versus 1 : 1 or 1 : 1 versus
1.5 : 1) of the same lipid formulation.
C30-20, DC-Chol, and EPC-containing lipoplexes at various
N/P molar charge ratios was assessed using a gel retardation
assay.Thenegatively charged plasmidDNA,when interacting
with sufficient cationic lipids, forms a neutral or net positive
complex that will not migrate through the agarose gel. As
seen in Figure 4, all formulations revealed partial or total
DNA retention, demonstrating cationic lipid/DNA lipoplex
formation. An increase in N/P molar charge ratio resulted in
an increase inDNA retention. C20-18/Chol and C30-20/Chol
formulations revealed a higher degree of complexation with
DNA, as revealed by a diminished DNA migration band,
when compared with C20-18, C20-20, and C30-20 formula-
tions (Figures 4(a) and 4(b)). The reference lipids DC-Chol
and EPC showed a similar trend, with higher DNA retention
with increasing N/P molar ratios (Figures 4(c) and 4(d)).
Our plasmid binding results are in accordance with previous
outcomes [13, 15], where C20-20 and C30-20 lipoplexes
formulated with DNA also revealed partial retention in a gel
retardation assay at low N/P charge ratios.
3.2. Toxicity of the Lipoplexes Is Concentration Dependent
in RPE Cells. ARPE-19 cells were cultured in the presence
of C20-18, C20-20, C30-20, DC-Chol, and EPC lipoplexes
at varying N/P molar charge ratios, and cell viability was
assessed after 24, 48, and 72 h (Figures 5, 6, 7, 8, and 9).
A decrease in cell viability below 75% was defined as the
cytotoxicity threshold, according to the ISO standard for
biological evaluation of medical devices [17].
Toxicity was concentration dependent (increasing with
increased N/P molar charge ratio) and time dependent
(duration of the incubation period) as previously described
[18]. Lipoplex C20-20 was found to be more cytotoxic than
C20-18 and C30-20. The reference lipids exhibit toxicity
comparable with C20-20.
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Figure 4: Gel retardation assays with lipoplexes C20-18 (a), C20-20 and C30-20 (b), DC-Chol (c), and EPC (d) with DOPE and Chol as
colipids. Molar charge ratios N/P used were 0.5 : 1, 1 : 1, and 1.5 : 1. Retention of DNA increases with increasing molar charge ratios.
Based on the cytotoxicity results, the 0.5 : 1 N/P molar
charge ratio was subsequently used in transfection assays and
in vivo assays for all formulations due to lower cytotoxicity.
3.3. Toxicity of C20-20/DOPE Lipoplex under In Vivo Con-
ditions. To evaluate whether the level of toxicity observed
in vitro was similar for in vivo, C20-20/DOPE lipoplexes
prepared in PBS at a N/P molar charge ratio of 0.5 : 1 were
administered by intravitreal injection to the eyes of C57BL6
mice. After 14 days, mice were sacrificed and the eyes were
enucleated and used for Iba1 detection by immunohisto-
chemistry or stained with hematoxylin and eosin for assess-
ment of retinal integrity and inflammation. Iba1 is a calcium-
binding protein characteristic of microglia that is expressed
when the microglia is reactive, that is, in situations where
inflammation occurs [19]. Our results showed that retinas
of mice injected with C20-20/DOPE lipoplexes at the N/P
molar charge ratio 0.5 : 1 (Figure 10) revealed microglia in the
nonreactive state, with short cellular ramifications, indicating
the absence of inflammation in the retina.The control, which
is the contralateral noninjected eye, also showed similar
microglia morphology in its nonreactive state. These results
confirm that C20-20 is not toxic when administered in vivo
in the retina of C57Bl6 mice.
Administration of drugs by intravitreal injection can
result in morphological disruption of the retinal structure,
caused by the injection procedure and tissue inflammation.
Hematoxylin and eosin staining (Figure 11) showed no mor-
phological disruption of the retina in the in vivo study.
3.4. Transfection Efficiency of C20-18, C20-20, and C30-
20 Lipoplexes in RPE Cells. We investigated the in vitro
transfection efficiency of the C20-18, C20-20, and C30-20
lipoplexes in retinal cells using a plasmid coding for GFP
and assessing its expression qualitatively by fluorescence
microscopy and quantitatively by flow cytometry. ARPE-
19 cells were transfected with C20-18, C20-20, and C30-20
lipoplexes with either Chol orDOPE as colipid at aN/Pmolar
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Figure 5: DC-Chol lipoplex cytotoxicity. ARPE-19 cell viability for
DC-Chol lipoplexes with either Chol or DOPE as colipid at various
N/P ratios incubated up to 72 h. Horizontal line at 75% viability
represent the threshold according to the ISO standard for in vitro
testing of biological devices. C+ represents untreated cells and C−
represents cells treated to induce cell death. Statistical significance
(∗) of 95% (𝑃 < 0.05).
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Figure 6: EPC lipoplex cytotoxicity. ARPE-19 cell viability for EPC
lipoplexes with either Chol or DOPE as colipids at various N/P
molar charge ratios incubated up to 72 h. Horizontal line at 75%
viability represents the threshold according to the ISO standard
for in vitro testing of biological devices. C+ represents untreated
cells and C− represents cells treated to induce cell death. Statistical
significance (∗) of 95% (𝑃 < 0.05).
ratio of 0.5 : 1; transfection was evaluated by GFP expression
after 72 h (Figures 12 and 13 and Supplementary Figure S2
available online at http://dx.doi.org/10.1155/2014/703253). For
polyene and reference lipids alike, all DOPE formulated
lipoplexes, with the exception of C30-20, revealed greater
transfection efficiency than those formulations with Chol
as colipid (Figure 13). Of the polyene lipids studied, the
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Figure 7: C20-18 lipoplex cytotoxicity. ARPE-19 cell viability for
C20-18 lipoplexes with either Chol or DOPE as colipid at various
N/P ratios incubated up to 72 h. Horizontal line at 75% viability
represents the threshold according to the ISO standard for in vitro
testing of biological devices. C+ represents untreated cells and C−
represents cells treated to induce cell death. Statistical significance
(∗) of 95% (𝑃 < 0.05).
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Figure 8: C20-20 lipoplex cytotoxicity. ARPE-19 cell viability for
C20-20 lipoplexes with either Chol or DOPE as colipid at various
N/P ratios incubated up to 72 h. Horizontal line at 75% viability
represents the threshold according to the ISO standard for in vitro
testing of biological devices. C+ represents untreated cells and C−
represents cells treated to induce cell death. Statistical significance
(∗) of 95% (𝑃 < 0.05).
C20-20/DOPE formulation revealed the greatest transfection
efficiency, with an average of 8%, followed by C20-18/DOPE
with 6% (Figure 13). Upon comparison of the polyene
lipoplexes with DC-Chol and EPC lipoplexes, C20-18 and
C20-20 lipoplexes revealed greater competitive transfection
efficiencies whenChol was used as colipid (Figures 12 and 13).
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Figure 9: C30-20 lipoplex cytotoxicity. ARPE-19 cell viability for
C30-20 lipoplexes with either Chol or DOPE as colipid at various
N/P ratios incubated up to 72 h. Horizontal line at 75% viability
represents the threshold according to the ISO standard for in vitro
testing of biological devices. C+ represents untreated cells and C−
represents cells treated to induce cell death. Statistical significance
(∗) of 95% (𝑃 < 0.05).
The transfection efficiency of C20-20 and C30-20
lipoplexes at N/P molar charge ratio of 0.5 : 1 containing
either Chol or DOPE as colipid was also assessed in D407
cells against the positive control, GeneJuice (supplementary
Figure S1). As was found with the ARPE-19 cell line, the C20-
20/DOPE formulation outperformed the corresponding
Chol formulation in the D407 cell line (supplementary
Figure S1). In addition, C20-20/DOPE revealed a level of
transfection competitive to the control GeneJuice, whereas
the C30-20 lipid revealed only a low level of transfection
with Chol as colipid.
4. Discussion
Cationic polyene lipids were evaluated for their potential to
carry DNA into retinal cells. Transfection efficiency was cor-
related with molecular structure, lipoplex size, zeta potential,
biocompatibility, and the presence of colipids. DOPE and
cholesterol increase DNA delivery and thus were employed
as colipids. DOPE, often referred to as a “fusogenic lipid,”
could alter the packing of the hydrophobic chains within
the lipoplex [10] by promoting a nonlamellar structure, thus
destabilizing the endosomal membrane and releasing DNA
[7] upon membrane fusion between the lipoplex and the
endosome [8]. The addition of plasmid DNA to the self-
aggregated liposomes formed lipoplexes, which were char-
acterized for their physical properties and capacity of DNA
complexation. All liposomes showed some degree of com-
plexation with plasmid DNA; however, complete retention
of the lipoplexes in the gel retardation assay was not always
observed. With the exception of C20-20, the polyene lipids
complexed DNA more effectively when cholesterol was used
as colipid, while EPC and DC-Chol showed more complete
binding with formulations that contained DOPE (Figure 2).
It was expected that increasing the N/P molar ratio for those
lipoplex formulations with incomplete gel retardation would
result in complete DNA retention [20] at the expense of cell
viability.
The analysis of the physical properties of the lipoplexes,
summarized in Table 1, shows that some EPC and DC-Chol
formulations gave rise to large lipoplex sizes and high poly-
dispersity index (PdI). This is most likely due to aggregation
and fusion of liposomes during lipoplex formation [21].
Despite this observation, the sizes of the lipoplexes are in the
range of those generally considered adequate for in vitro cell
internalization, although a correlation between size, surface
charge, and transfection efficiency is still debatable [10].
Almofti et al. demonstrated for the cationic lipid DC-6-14
that lipoplex size increased lipoplex transfection [22]. With
the exception of DC-Chol, all DOPE formulations revealed
better transfection efficiencies with larger lipoplex compared
to Chol formulations. This can be explained by the multiple
endocytic mechanisms existing in the cells for internalization
of lipoplexes of different sizes [7].
Zeta potential reflects the surface charge and lipoplex
stability: ZP > ±30mV indicates stable particles, and
ZP < ±10mV suggests unstable particles with a tendency to
aggregation [10].
Our lipoplexes presented negative zeta potential values
between −30 ± 2 and −66 ± 1mV. Although a positively
charged lipoplex interacts more favorably with the negative
charged biological membranes, it is not a necessary condition
for transfection [9] and, as shown in Figures 12 and 13, C20-
20/DOPE andC20-18/DOPE lipoplexes were able to transfect
retinal cells.
Negative ZP values most likely derive from DNA bound
to the outer shell of the lipoplexes and from the phosphate
groups associated with the solvent (PBS) that remains close
to the surface of the lipoplexes.
Successful gene carriers do not only transfect efficiently,
but they also need to be biocompatible with the organism
and target tissue. In vitro testing showed that the lipoplexes
have increased in vitro toxicity with increasing N/P molar
ratio and incubation period, in line with reference lipids
DC-Chol, EPC, and other cationic lipids [18, 23]. Toxicity
is lipoplex specific and tissue specific, dose dependent and
route dependent. Lipoplex formulations can be modified to
reduce toxicity or to promote transfection efficiency; one
example is PEGylation, which can control lipoplex size and
increase circulation time in vivo [7]. In the retina, toxicity and
inflammation can be evaluated by morphological analysis
of the retina and by immunohistochemistry detection of
inflammatory markers, such as the microglia. The microglia
consists of macrophages and monocytes and is a normal
constituent in the retina, mainly distributed in the nerve fiber
layer and ganglion cell layer [24]. In its nonreactive state,
ramified microglia can be observed in the tissue. However,
when tissue is damaged, microglial cells migrate to all retinal
layers, retract cell processes (ramifications), and increase
cell size [25]. Our results show in vivo compatibility of
C20-20 with the retinal tissue, as shown by the absence of
10 BioMed Research International
Injected
C20-20/dope/DNA
Injected and electroporated
C20-20/dope/DNA
Noninjected
50𝜇m
Figure 10: Immunohistochemistry detection of Iba1 in mouse retinas injected with C20-20/DOPE lipoplexes at the N/P molar charge ratio
0.5 : 1. Magnification: 100x and scale bar: 50 𝜇m.
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Figure 11: Hematoxylin and eosin staining of mouse retinas injected with C20-20/DOPE lipoplexes at the N/P molar charge ratio 0.5 : 1,
showing the maintenance of the integrity of the retinal layered structure. Magnification: 100x and scale bar: 50 𝜇m.
morphological alterations in the retina and by nonreactive
microglia.
The efficiency of in vitro gene delivery was evaluated
with a plasmid coding for the GFP reporter gene, through
detection of GFP-positive cells. C20-20 and the C20-18
formulations showed greater transfection efficiency relative
to C30-20 when either DOPE or Chol was used as colipid. All
lipid-DOPE formulations showed enhanced transfection effi-
ciency when compared with lipid-Chol formulations. DOPE
probably facilitates lipoplex phase transitions from lamellar
to inverted hexagonal packing, which allows an effective
fusion of the lipoplex and the cellular endocytic membrane
[26, 27]. It has previously been demonstrated that lipoplexes
of EPC, C20-20, and C30-20, with either DOPE or Chol, gave
rise to lamellar morphologies as shown by small-angle X-
ray scattering [12]. However, only those lamellar lipoplexes
containingDOPE are expected to invert to hexagonal packing
in the endosome.
Although transfection in ARPE-19 cells was higher for
the DC-Chol/DOPE and EPC/DOPE lipoplexes, transfec-
tion efficiencies of the C20-18/DOPE and C20-20/DOPE
lipoplexes are noteworthy when compared to other investi-
gations reporting considerably lower efficiencies [28].
In an attempt to further compare the relative transfection
efficiency of C20-20 and C30-20, we tested the same for-
mulations in D407 cells (supplementary Figure S1), another
cell line from the retina, but with a faster mitotic rate than
ARPE-19. We observed with these cells a greater transfection
efficiency than with ARPE-19 cells, which is most likely due
to the higher mitotic rate, since during mitosis the nuclear
membrane is disaggregated and therefore nuclear penetration
of nucleic acids is facilitated.
Remarkably, C20-20 displayed greater transgene effi-
ciency than C30-20 in both cell lines tested. The retinoic
lipids C20-18 and C20-20 may therefor enter the nucleus via
a possible retinoid receptor [29]. Further studies are required
to investigate a possible retinoid receptor mediated nuclear
uptake mechanism.
C20-18/Chol and C20-20/Chol performed comparably
to references DC-Chol and EPC. C20-20/DOPE lipoplexes
delivered DNA in vitro to RPE cells and were biocompatible
during in vivo applications. These results encourage us to
optimize and characterize this process.
5. Conclusion
Cationic liposomes formulated from polyene lipids C20-18,
C20-20, and C30-20 and a neutral colipid were combined
with a GFP-coded plasmid DNA for studies in retina cells.
Gel electrophoresis was used to confirm the formation of
lipoplexes in all formulations containing either DOPE or
Chol as colipid. The diameters of lipoplexes were relatively
large and variable; however, this did not appear to hinder
transfection, since for a given cationic lipid larger lipoplexes
gave rise to greater transfection (Table 1 and Figure 13).
Toxicity associated with the polyene lipids under in vitro
conditions was, as anticipated, concentration dependent and
increased with increasing N/P ratio. Toxicity was also found
to increase with increasing incubation period, in line with the
formulations for reference lipids DC-Chol and EPC.
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Figure 12: Qualitative assessment of lipoplex transfection. ARPE-19 cells were incubated with lipoplexes containing lipids C20-18, C20-20, or
C30-20 against reference lipids DC-Chol and EPC with either Chol or DOPE as colipid at N/P molar ratio 0.5 : 1 for 4 h and GFP-expressing
cells evaluated by fluorescence microscopy after 72 h. Magnification: 100x and scale bar: 100 𝜇m.
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Figure 13: The transfection efficiency of lipoplexes. ARPE-19 cells
were incubated with lipoplexes containing lipids C20-18, C20-20,
or C30-20 against reference lipids DC-Chol and EPC with either
Chol or DOPE as colipid at N/P molar ratio 0.5 : 1 for 4 h and
transfection efficiencies, measured by GFP expression, determined
by flow cytometry after 72 h. Statistical significance (∗) of 95% (𝑃 <
0.05).
C20-20 was found to have greater in vitro cytotoxicity
than C20-18 or C30-20. Nonetheless, C20-20 showed no
evidence of inflammation in the mouse retina. In vitro trans-
fection efficiencies of 6% and 8% were achieved with ARPE-
19 cells with C20-18/DOPE and C20-20/DOPE, respectively.
Furthermore, DNA delivery using C20-20/DOPE outper-
formed C30-20 in D407 retinal cells and revealed a level of
transfection competitive to reference GeneJuice.
Overall, C20-20/DOPE gave promising results for ocular
gene therapy. Future work is directed to optimize formula-
tions for in vivo ocular gene delivery.
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